Abstract
Background
The STOPPFrail criteria were developed to assist physicians in deprescribing medications among frail patients approaching end of life. We aimed to measure the prevalence of potentially inappropriate medications (PIMs) and to describe changes over time, using STOPPFrail, in frail nursing home residents (NHRs) with limited life expectancy included in a medication review trial.
Methods
We conducted a post-hoc analysis of the COME-ON study, a cluster-controlled trial that evaluated the effect of a complex intervention on appropriateness of prescribing in Belgian nursing homes. We identified NHRs eligible for the application of STOPPFrail based on functional status, comorbidities, level of care and survival. PIM use was measured at baseline and at 8 months. Changes over time were compared in the control group (CG) and intervention group (IG).
Results
At baseline, 308 NHRs met the STOPPFrail eligibility criteria, of whom 196 (64.1%) had one or more PIM. At 8 months, among the 218 NHRs who were alive, there was an absolute reduction in the prevalence of PIMs of 9.1% in the CG (p < 0.05) and 10.2% in the IG (p < 0.05). We found large reductions for some medications (e.g. proton pump inhibitors) but no reduction for others (e.g. calcium). The percentage of NHRs with one or more PIM discontinued without a new PIM initiated was higher in the IG than the CG but the difference was not significant (35.1% vs 23.6%, p = 0.127).
Conclusion
Among frail NHRs with poor survival prognosis, a significant and encouraging decrease in PIM prevalence over time was observed, probably facilitated by medication reviews. The overall prevalence of PIMs remained high, however.
Similar content being viewed by others
References
Jokanovic N, Tan EC, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc. 2015;16(6):535 e1-12. https://doi.org/10.1016/j.jamda.2015.03.003.
Morin L, Laroche ML, Texier G, Johnell K. Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J Am Med Dir Assoc. 2016;17(9):862 e1-9. https://doi.org/10.1016/j.jamda.2016.06.011.
Jano E, Aparasu RR. Healthcare outcomes associated with beers' criteria: a systematic review. Ann Pharmacother. 2007;41(3):438–47. https://doi.org/10.1345/aph.1H473.
Perri M 3rd, Menon AM, Deshpande AD, Shinde SB, Jiang R, Cooper JW, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother. 2005;39(3):405–11. https://doi.org/10.1345/aph.1E230.
Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med. 2005;165(1):68–74. https://doi.org/10.1001/archinte.165.1.68.
Albert SM, Colombi A, Hanlon J. Potentially inappropriate medications and risk of hospitalization in retirees: analysis of a US retiree health claims database. Drugs Aging. 2010;27(5):407–15. https://doi.org/10.2165/11315990-000000000-00000.
Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging. 2005;22(1):69–82.
Dalleur O, Spinewine A, Henrard S, Losseau C, Speybroeck N, Boland B. Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging. 2012;29(10):829–37.
Ruggiero C, Dell'Aquila G, Gasperini B, Onder G, Lattanzio F, Volpato S, et al. Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging. 2010;27(9):747–58. https://doi.org/10.2165/11538240-000000000-00000.
Bo M, Quaranta V, Fonte G, Falcone Y, Carignano G, Cappa G. Prevalence, predictors and clinical impact of potentially inappropriate prescriptions in hospital-discharged older patients: a prospective study. Geriatr Gerontol Int. 2018;18(4):561–8. https://doi.org/10.1111/ggi.13216.
O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8. https://doi.org/10.1093/ageing/afu145.
By the American Geriatrics Society Beers Criteria Update Expert P. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46. https://doi.org/10.1111/jgs.13702.
Khodyakov D, Ochoa A, Olivieri-Mui BL, Bouwmeester C, Zarowitz BJ, Patel M, et al. Screening tool of older person's prescriptions/screening tools to alert doctors to right treatment medication criteria modified for U.S. Nursing Home Setting. J Am Geriatr Soc. 2017;65(3):586–91. https://doi.org/10.1111/jgs.14689.
Nyborg G, Straand J, Klovning A, Brekke M. The Norwegian General Practice-Nursing Home criteria (NORGEP-NH) for potentially inappropriate medication use: a web-based Delphi study. Scand J Prim Health Care. 2015;33(2):134–41. https://doi.org/10.3109/02813432.2015.1041833.
Lavan AH, Gallagher P, Parsons C, O'Mahony D. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing. 2017;46(4):600–7. https://doi.org/10.1093/ageing/afx005.
Curtin D, O'Mahony D, Gallagher P. Drug consumption and futile medication prescribing in the last year of life: an observational study. Age Ageing. 2018. https://doi.org/10.1093/ageing/afy054.
Paque K, De Schreye R, Elseviers M, Vander Stichele R, Pardon K, Dilles T, et al. Discontinuation of medications at the end of life: a population study in Belgium, based on linked administrative databases. Br J Clin Pharmacol. 2019;85(4):827–37. https://doi.org/10.1111/bcp.13874.
Lavan AH, O'Mahony D, Gallagher P. STOPPFrail (Screening Tool of Older Persons' Prescriptions in Frail adults with a limited life expectancy) criteria: application to a representative population awaiting long-term nursing care. Eur J Clin Pharmacol. 2019;75(5):723–31. https://doi.org/10.1007/s00228-019-02630-3.
Paque K, Elseviers M, Vander Stichele R, Pardon K, Vinkeroye C, Deliens L, et al. Balancing medication use in nursing home residents with life-limiting disease. Eur J Clin Pharmacol. 2019;75(7):969–77. https://doi.org/10.1007/s00228-019-02649-6.
Paque K, Elseviers M, Vander Stichele R, Dilles T, Pardon K, Deliens L, et al. Associations of potentially inappropriate medication use with four year survival of an inception cohort of nursing home residents. Arch Gerontol Geriatr. 2019;80:82–7. https://doi.org/10.1016/j.archger.2018.10.011.
Anrys P, Strauven G, Boland B, Dalleur O, Declercq A, Degryse JM, et al. Collaborative approach to Optimise MEdication use for Older people in Nursing homes (COME-ON): study protocol of a cluster controlled trial. Implement Sci. 2016;11:35. https://doi.org/10.1186/s13012-016-0394-6.
Anrys PMS, Strauven GC, Foulon V, Degryse JM, Henrard S, Spinewine A. Potentially inappropriate prescribing in Belgian nursing homes: prevalence and associated factors. J Am Med Dir Assoc. 2018. https://doi.org/10.1016/j.jamda.2018.06.010.
Strauven G, Anrys P, Vandael E, Henrard S, De Lepeleire J, Spinewine A, et al. Cluster-controlled trial of an intervention to improve prescribing in nursing homes study. J Am Med Dir Assoc. 2019;20(11):1404–11. https://doi.org/10.1016/j.jamda.2019.06.006.
Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992;41(3):237–48. https://doi.org/10.1016/0165-1781(92)90005-n.
Anrys P, Boland B, Degryse JM, De Lepeleire J, Petrovic M, Marien S, et al. STOPP/START version 2-development of software applications: easier said than done? Age Ageing. 2016;45(5):589–92. https://doi.org/10.1093/ageing/afw114.
R Core Team. R: a language and environnment for statistical computing. Austria: R Foundation for Statistical Computing V; 2016. https://www.R-project.org/.
Curtin D, Jennings E, Daunt R, Curtin S, Randles M, Gallagher P, et al. Deprescribing in older people approaching end of life: a randomized controlled trial using STOPPFrail criteria. J Am Geriatr Soc. 2020;68(4):762–9. https://doi.org/10.1111/jgs.16278.
Beuscart JB, Knol W, Cullinan S, Schneider C, Dalleur O, Boland B, et al. International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy. BMC Med. 2018;16(1):21. https://doi.org/10.1186/s12916-018-1007-9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Author contributions
AF, AS, JBB and PA designed the study. AF, AS, PA, JBB, OD and SH analysed the data. AF, PA, OD, AS, VF and JBB wrote the manuscript. All authors contributed to and approved the final version of the manuscript.
Funding
No specific funding has been received for this work. The original COME-ON study was funded by the National Institute for Health and Disability Insurance (NIHDI). The funding body had a limited role in the study design but no role in data collection, implementation, analysis and decision to publish the results.
Conflict of interest
The authors disclose no financial and personal relationships with other people or organizations that could inappropriately influence their work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fournier, A., Anrys, P., Beuscart, JB. et al. Use and Deprescribing of Potentially Inappropriate Medications in Frail Nursing Home Residents. Drugs Aging 37, 917–924 (2020). https://doi.org/10.1007/s40266-020-00805-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40266-020-00805-7